zelfie semaglutide Ozempic® Drug Information Developed by Novo Nordisk Tirzepatide vs. Semaglutide for Weight

These results were more profound in women and older adults

Gastrointestinal: Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death, ileus General Disorders and Administration Site Conditions: Allergic reactions: rash and pruritus Hepatobiliary: Elevations of liver enzymes, hyperbilirubinemia, cholestasis, cholecystitis, cholelithiasis requiring cholecystectomy, hepatitis Immune system: Angioedema and anaphylactic reactions Metabolism and nutrition: Dehydration resulting from nausea, vomiting and diarrhea Neoplasms: Medullary thyroid carcinoma Nervous system: Dysgeusia, dizziness Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation

Commonly reported symptoms include: Nausea Gastrointestinal discomfort Transient appetite changes Fatigue or headache These effects are generally dose-dependent and tend to diminish over time as the body adjusts

Zepbound is an FDA-approved medication that combines tirzepatide, a GLP-1 receptor agonist, with the goal of treating obesity

This coordination supports safer titration and faster optimization than purchasing from unaccountable sources

If pancreatitis is suspected, promptly discontinue JANUMET